Next Article in Journal
Insulin Signaling in Intestinal Stem and Progenitor Cells as an Important Determinant of Physiological and Metabolic Traits in Drosophila
Previous Article in Journal
Salivary Histatin 1 and 2 Are Targeted to Mitochondria and Endoplasmic Reticulum in Human Cells

This is an early access version, the complete PDF, HTML, and XML versions will be available soon.

Open AccessArticle

TNFa and IL2 Encoding Oncolytic Adenovirus Activates Pathogen and Danger-Associated Immunological Signaling

1
Cancer Gene Therapy Group, Faculty of Medicine, TRIMM, University of Helsinki, Haartmaninkatu 3, 00290 Helsinki, Finland
2
TILT Biotherapeutics Ltd., Haartmaninkatu 3, 00290 Helsinki, Finland
3
Amsterdam UMC, Clinical Genetics, Section Oncogenetics, Cancer Center Amsterdam, De Boelelaan 1117, 1118, 1081 HV Amsterdam, The Netherlands
4
Department of Obstetrics and Gynecology, Helsinki University Hospital, Haartmaninkatu 2, 00290 Helsinki, Finland
5
Helsinki University Hospital Comprehensive Cancer Center, Paciuksenkatu 3, 00290 Helsinki, Finland
*
Author to whom correspondence should be addressed.
Cells 2020, 9(4), 798; https://doi.org/10.3390/cells9040798 (registering DOI)
Received: 28 February 2020 / Revised: 23 March 2020 / Accepted: 24 March 2020 / Published: 26 March 2020
(This article belongs to the Special Issue Immunology of Cell Death in Cancer Immunotherapy)
In order to break tumor resistance towards traditional treatments, we investigate the response of tumor and immune cells to a novel, cytokine-armed oncolytic adenovirus: Ad5/3-d24-E2F-hTNFa-IRES-hIL2 (also known as TILT-123 and OAd.TNFa-IL2). There are several pattern recognition receptors (PRR) that might mediate adenovirus-infection recognition. However, the role and specific effects of each PRR on the tumor microenvironment and treatment outcome remain unclear. Hence, the aim of this study was to investigate the effects of OAd.TNFa-IL2 infection on PRR-mediated danger- and pathogen-associated molecular pattern (DAMP and PAMP, respectively) signaling. In addition, we wanted to see which PRRs mediate an antitumor response and are therefore relevant for optimizing this virotherapy. We determined that OAd.TNFa-IL2 induced DAMP and PAMP release and consequent tumor microenvironment modulation. We show that the AIM2 inflammasome is activated during OAd.TNFa-IL2 virotherapy, thus creating an immunostimulatory antitumor microenvironment.
Keywords: aenovirus; virotherapy; immunotherapy; AIM2; oncolytic virus; TILT-123; immunological cell death; DAMP; PAMP aenovirus; virotherapy; immunotherapy; AIM2; oncolytic virus; TILT-123; immunological cell death; DAMP; PAMP
MDPI and ACS Style

Heiniö, C.; Havunen, R.; Santos, J.; Lint, K.; Cervera-Carrascon, V.; Kanerva, A.; Hemminki, A. TNFa and IL2 Encoding Oncolytic Adenovirus Activates Pathogen and Danger-Associated Immunological Signaling. Cells 2020, 9, 798.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop